rosiglitazone (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View rosiglitazone's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

Source	Relation	Target	Evidence
rosiglitazone Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	ASPN Gene (Entity type)	0.00404121
rosiglitazone Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	sodium-gualenate Compound (Entity type)	0.382209450006485
rosiglitazone Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	HPGD Gene (Entity type)	-0.0041196863
rosiglitazone Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	G0S2 Gene (Entity type)	0.0036450026
rosiglitazone Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	GPNMB Gene (Entity type)	-0.004250235
rosiglitazone Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	CILP Gene (Entity type)	0.0050524715
rosiglitazone Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	CEMIP Gene (Entity type)	-0.0051348484
rosiglitazone Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	Saxagliptin Compound (Entity type)	0.377725750207901
rosiglitazone Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	CXCL14 Gene (Entity type)	0.0041892934
rosiglitazone Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	ENO2 Gene (Entity type)	-0.004307882

rosiglitazone
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
ASPN
Gene (Entity type)
0.00404121

rosiglitazone
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
sodium-gualenate
Compound (Entity type)
0.382209450006485

rosiglitazone
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
HPGD
Gene (Entity type)
-0.0041196863

rosiglitazone
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
G0S2
Gene (Entity type)
0.0036450026

rosiglitazone
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
GPNMB
Gene (Entity type)
-0.004250235

rosiglitazone
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
CILP
Gene (Entity type)
0.0050524715

rosiglitazone
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
CEMIP
Gene (Entity type)
-0.0051348484

rosiglitazone
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
Saxagliptin
Compound (Entity type)
0.377725750207901

rosiglitazone
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
CXCL14
Gene (Entity type)
0.0041892934

rosiglitazone
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
ENO2
Gene (Entity type)
-0.004307882

DISPLAY PER PAGE

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
Loading results...

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.